XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2019
Stockholders' Equity Note [Abstract]  
Share-based Compensation, Stock Options, Activity
Stock option activity for options granted under the 2017 Plan during the three months ended March 31, 2019 is presented in the table below:
 
Number of Shares Available
 
Number of Options Outstanding
 
Weighted-average Exercise Price
 
Weighted-average Remaining Contractual Term (years)
 
Aggregate Intrinsic Value
Balance at December 31, 2018
157,881

 
343,550

 
$
28.97

 
8.95
 
$
840

Annual additional options authorized
153,814

 

 

 
 
 
 
Granted
(89,700
)
 
89,700

 
$
13.76

 
 
 
 
Exercised

 

 

 
 
 
 
Forfeited
1,836

 
(1,836
)
 
$
16.64

 
 
 
 
Balance at March 31, 2019
223,831

 
431,414

 
$
25.86

 
8.92
 
$



Stock option activity for the Pre-2017 Non-Qualified Stock Options for the three months ended March 31, 2019 is presented in the table below:
 
Number of Shares
 
Weighted- average Exercise Price
 
Weighted- average Remaining Contractual Term (years)
 
Aggregate Intrinsic Value (in Thousands)
Outstanding at December 31, 2018
2,885,500

 
$
7.30

 
6.04
 
$
20,633,100

Exercised
(80,000
)
 
7.52

 
 
 
 

Forfeited
(4,865
)
 
10.00

 
 
 
 
Outstanding at March 31, 2019
2,800,635

 
$
7.29

 
5.77
 
$
16,358,456

Exercisable at March 31, 2019
2,695,766

 
$
7.21

 
5.76
 
$
15,932,550

Warrant activity for the three months ended March 31, 2019 is presented in the table below:
 
Number of Shares
 
Weighted- average Exercise Price
 
Weighted- average Remaining Contractual Term (years)
 
Aggregate Intrinsic Value (in Thousands)
Outstanding at December 31, 2018
353,610

 
$
9.78

 
4.36
 
$
1,181

Exercised

 
$

 
 
 
 

Outstanding at March 31, 2019
353,610

 
$
9.78

 
4.36
 
$
1,181

Exercisable at March 31, 2019
353,610

 
$
9.78

 
4.36
 
$
1,181

Schedule of Nonvested Share Activity
A summary of the status of the Company’s non-vested Pre-2017 Non-Qualified Stock Options as of March 31, 2019 is presented below:
 
Number of Options
 
Weighted Average Grant Date Fair Value
Non-vested at March 31, 2019
109,734

 
$
7.76

A summary of the status of the Company’s non-vested options granted under the 2017 Plan as of March 31, 2019 is presented in the following table:
 
Number of Shares
 
Weighted Average Grant Date Fair Value Per Share
Balance at March 31, 2019
431,414

 
$
25.34

Vested
(106,278
)
 
30.53

Non-vested at March 31, 2019
325,136

 
$
23.64

Schedule of Assumptions Used in the Valuation
The assumptions used in the valuation of options granted under the 2017 Plan during the three months ended March 31, 2019 are as follows:
 
For the Three Months Ended March 31, 2019
Market value of stock on measurement date
$13.61 to $14.62

Risk-free interest rate
2.41% to 2.57%

Dividend yield

Volatility factor
121%

Term
6.25 Years